Zoeti a Aktie

160,48USD 3,09USD 1,96%
Zoeti a für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: A1KBYX / ISIN: US98978V1035
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 11 300 12 100 13 800 14 100 13 800
Umsatz pro Mitarbeiter in Mio. EUR 0,59 0,64 0,59 0,61 0,67

Bilanz (in Mio. USD) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 6 611 6 930 7 506 6 343 5 986
Summe Anlagevermögen 6 998 6 970 7 419 7 943 8 251
Summe Aktiva 13 609 13 900 14 925 14 286 14 237

Bilanz (in Mio. USD) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 9 836 9 356 10 522 9 295 9 467
Summe Eigenkapital 3 773 4 544 4 403 4 991 4 770
Summe Passiva 13 609 13 900 14 925 14 286 14 237

Adresse

10 Sylvan Way, 07054 Parsippany
Telefon +1 (973) 822-7000
Internet http://www.zoetis.com

Management

Abhay Nayak
Head-Strategy & Accelerated Growth Businesses
Antoinette R. Leatherberry
Independent Director
Frank A. D'Amelio
Independent Director
Gavin D. K. Hattersley
Independent Director
Gregory Norden
Independent Director
Jamie Andrew Brannan
Chief Commercial Officer
Julie A Fuller
Chief Human Resources Officer & Executive VP
Keith Sarbaugh
Executive VP, Chief Digital & Technology Officer
Kristin C. Peck
Chief Executive Officer & Director
Louise M. Parent
Independent Director
Michael B. McCallister
Non-Executive Chairman
Paul M. Bisaro
Independent Director
Richard E. Goldstein
Chief Medical Officer & Head-Medical Affairs
Rimma Driscoll
EVP, Head-Global Strategy & Business Development
Robert J. Polzer
President-Research & Development, Executive VP
Robert W. Scully
Independent Director
Roxanne Lagano
Secretary, Executive VP & General Counsel
Sanjay Khosla
Independent Director
Steven Frank
Head-Investor Relations
Vanessa A. Broadhurst
Independent Director
Wetteny Joseph
CFO, EVP & Head-Business Development
William Dorsey
Head-US Operations
Willie M. Reed
Independent Director